Future Directions in Therapies for Acute Respiratory Distress Syndrome
- PMID: 39443010
- DOI: 10.1016/j.ccm.2024.08.014
Future Directions in Therapies for Acute Respiratory Distress Syndrome
Abstract
Acute respiratory distress syndrome (ARDS) is caused by a complex interplay among hyperinflammation, endothelial dysfunction, and alveolar epithelial injury. Targeted treatments toward the underlying pathways have been unsuccessful in unselected patient populations. The first reliable biological subphenotypes reflective of these biological disease states have been identified in the past decade. Subphenotype targeted intervention studies are needed to advance the pharmacologic treatment of ARDS.
Keywords: ARDS; Inflammation; Phenotype; Treatment.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure L. D.J. Bos reports funding from Health Holland, Longfonds, ZonMw, Innovative Medicine Initiative and has consulted for Astra Zeneca, Pfizer, Sobi, Novartis, CSL Behring, Scailyte, and Santhera. All financial contributions were paid to the institution. J.E. Millar and K. Reddy declare no COI.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous